Merck and Ridgeback Biotherapeutics Begin P-III (MOVe-NOW) Trial of Lagevrio (Molnupiravir) to Treat COVID-19 in High-Risk Adults
Shots: The P-III (
Novavax’s 2024-2025 Formula COVID-19 Vaccine Receives Emergency Use Authorization in the US
Shots: Novavax’s COVID-19 vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV27...
AB Science Provides Update on P-II Trial Design of Masitinib for COVID-19
Shots: The P-II (AB20001) trial was designed to assess masitinib + isoquercetin in...
Pfizer and BioNTech Report the CHMP’s Positive Opinion of Comirnaty JN.1 Vaccine for COVID-19
Shots: The CHMP has granted positive opinion to Omicron JN.1-adapted COVID-19 vacc...
The EC Approves Biogen’s Tofidence (Biosimilar, Roactemra) for Treating Arthritis and COVID-19
Shots: The EC has approved Tofidence (IV), a biosimilar version of Roactemra, to t...
